Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
NANJING, China, Aug. 17 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE:SCR), a leading manufacturer and supplier of branded generic and innovative...
NANJING, China, Aug. 5 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic and innovative anti-cancer pharmaceuticals in China...
South China Resources PLC 01 September 2008 South China Resources Plc / Index: AIM / Epic: SCR / Sector: Natural Resources 1st September 2008 South China Resources PLC ('SCR' or 'the...
South China Resources PLC 07 August 2008 South China Resources Plc / Index: AIM / Epic: SCR / Sector: Natural Resources 7th August 2008 South China Resources PLC ('SCR' or 'the...
South China Resources PLC 06 August 2008 South China Resources Plc / Index: AIM / Epic: SCR / Sector: Natural Resources 06 August 2008 South China Resources PLC (*SCR* or *the...
South China Resources PLC 31 July 2008 For Immediate Release 31st July 2008 South China Resources plc (the "Company") Issue of Loan Stock The Board has approved the...
RNS Number:5707T South China Resources PLC 01 May 2008 1 May 2008 South China Resources PLC to purchase 70.5% beneficial interest in Elof open pit coal project near Johannesburg...
RNS Number:5718T AIM 01 May 2008 NOTICE (260) 01/05/2008 12:00 TEMPORARY SUSPENSION OF TRADING ON AIM SOUTH CHINA RESOURCES PLC At the request of the company trading on AIM...
RNS Number:1641T South China Resources PLC 25 April 2008 25th April 2008 South China Resources plc (AIM: SCR) Result of Annual General Meeting South China Resources plc...
NANJING, China, April 22 /Xinhua-PRNewswire Simcere Pharmaceutical Group (NYSE: SCR; 'Simcere'), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
